AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04262232 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapted Ca-HELP for Geriatric Cancer Patients
Description: Intervention group: This intervention will be informed by social-cognitive theory10-13 and modeled after the tailored education and coaching intervention (TEC) used for Ca-HELP previously and consists of six components: (1) Assessment of current knowledge, attitudes, and preferences; (2) clarification and correction of misconceptions about cancer pain control; (3) teaching of relevant concepts (education about cancer pain control); (4) planning (identifying goals of care, creating achievable goals of care, and creating strategies to communicate goals of care to providers and family members); (5) rehearsal of communication strategies using role play exercises; and (6) portrayal of learned skills (patient applies skills in visit with healthcare provider).
Study NCT06507449 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lithotripsy
Description: Calcified lesion preparation using lithotripsy before implantation of a drug-eluting stent
Study NCT06507449 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Orbital atherectomy
Description: Calcified lesion preparation using orbital atherectomy before implantation of a drug-eluting stent
Study NCT06507449 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High-pressure non-compliant balloon
Description: Calcified lesion preparation using high-pressure non-compliant balloon before implantation of a drug-eluting stent
Study NCT06507449 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optical coherence tomography
Description: Optical coherence tomography assessment of coronary arteries.
Study NCT06507449 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Coroventis Coroflow Cardiovascular System and PressureWire™ X Guidewire
Description: A coronary thermodilution system used for evaluate differences between the impact of calcified lesion preparation methods on coronary microvascular function.
Study NCT06336694 — intervention group
Intervention type: PROCEDURE
Intervention: surgery or diagnostic staging laparoscopy
Description: diagnosis of PDAC with peritoneal examination based on the surgical (for tumors treated with surgery) or diagnostic staging laparoscopy findings (for tumors treated with radiotherapy/chemotherapy)
Study NCT05503511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NPT 2042 (bumetanide analog) or Matching Placebo
Description: Soft gelatin capsules
Study NCT05513391 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant influenza vaccine (RIV4)
Description: Pharmaceutical form: solution for injection Route of administration: intramuscular
Study NCT05513391 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Quadrivalent influenza vaccine (IIV4)
Description: Pharmaceutical form: suspension for injection Route of administration: intramuscular
Study NCT05538078 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ozone gel
Description: application of Ozone gel after scaling by ultrasonic scaler in the bottom of periodontal pocket
Study NCT05538078 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozone gel
Description: application of Ozone gel after scaling by ultrasonic scaler in the bottom of periodontal pocket
Study NCT05027620 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor-cognitive exercise therapy in the home
Description: Participants engage in a progressive 10-week exercise program targeted at improving motor and cognitive function. Motor exercises target functional strength, gait and physical activity level. Training sessions occur 3 times weekly and supported by a digital application which has been adapted for people with Parkinson's disease. Weeks 1-2 focus solely on motor exercises. Dual-task (Motor-cognitive) exercises are introduced at week 3 and progressed until week 10. Participants are also encouraged to increase the physical activity levels during the 10 week period.~Weekly contact is made using the video function/ telephone with clinical specialists/ researchers. Two home visits will occur, the first one week prior to the intervention and at the 5-week period. Participants receive motivational messaging and reminders via the app during the intervention period.
Study NCT04880837 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Intervention
Description: Attend educational session
Study NCT04880837 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informational Intervention
Description: Receive handouts
Study NCT04880837 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Complete surveys
Study NCT04806906 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-486
Description: Investigational product will be dispensed on Day 1 of each treatment cycle. 300 mg CC-486 QD for 14 days of each 28-day treatment cycle
Study NCT05108402 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Phenotyping
Description: After inclusion in the study, between V1 and V4, patients will be phenotyped among: NaCl sensitive patients and non-NaCl sensitive patients. they will have a low sodium diet for 2 weeks. The first week without salt supplementation and the second with salt supplementation. At the end of V4, if patient is NaCl sensitive he will continue into treatment period and go through randomization, and for patient non-NaCl sensitive they will drop out of study.
Study NCT05108402 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Phenotyping
Description: After inclusion in the study, between V1 and V4, patients will be phenotyped among: NaCl sensitive patients and non-NaCl sensitive patients. they will have a low sodium diet for 2 weeks. The first week without salt supplementation and the second with salt supplementation. At the end of V4, if patient is NaCl sensitive he will continue into treatment period and go through randomization, and for patient non-NaCl sensitive they will drop out of study.
Study NCT05108402 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Phenotyping
Description: After inclusion in the study, between V1 and V4, patients will be phenotyped among: NaCl sensitive patients and non-NaCl sensitive patients. they will have a low sodium diet for 2 weeks. The first week without salt supplementation and the second with salt supplementation. At the end of V4, if patient is NaCl sensitive he will continue into treatment period and go through randomization, and for patient non-NaCl sensitive they will drop out of study.
Study NCT05108402 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Drug intake
Description: After being phenotyped, NaCl sensitive patients will continue the study in one of the 2 treatments arms : royal water (bottle) or salt sachet.
Study NCT05108402 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Drug intake
Description: After being phenotyped, NaCl sensitive patients will continue the study in one of the 2 treatments arms : royal water (bottle) or salt sachet.
Study NCT05588414 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Standardization of the sentinel node detection procedure
Description: All patients included in the study underwent the same pre- and intra-operative procedure, consisting of a double systematic sentinel node detection, using sequential ICG and isotopic technique. The patient is his own control for the analysis of the performance of the ICG technique alone compared to the combined ICG and isotopic technique.
Study NCT05461196 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CPMRx
Description: Patients use a mobile application to track pain medication usage and pain scores.
Study NCT05795322 — intervention group
Intervention type: OTHER
Intervention: Sound healing with tuning forks
Description: Over the course of a half-hour virtual session, a specially developed triple OM track created by tuning forks was played.
Study NCT06034782 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Fine Needle Aspiration
Description: Fine Needle Aspiration of a salivary gland tumor
Study NCT06034782 — intervention group
Intervention type: PROCEDURE
Intervention: Histologic Examination
Description: Histologic examination of resected salivary tumor
Study NCT04854226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Macronutrients_CARB
Description: Breast milk 150 to 170 mL/d; Target fortification: 9.0 g/100mL COH, 3.0 g/100mL protein, 4.0 g/100mL fat, 86.4 kcal/100mL
Study NCT04854226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Macronutrient_FAT
Description: Breast milk 150 to 170 mL/d; Target fortification: 5.5 g/100mL COH, 3.0 g/100mL protein, 5.5 g/100mL fat, 86 kcal/100mL
Study NCT05220293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Betamethasone Dipropionate Nasal Cream 0.0644%
Description: Betamethasone Dipropionate Nasal Cream 0.0644%, up to 5g per sinus.
Study NCT05220293 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pre-filled syringe and applicator device
Description: Cream is pre-filled to a syringe and applicator device to facilitate the topical application direct to the sinus under endoscopic guidance.
Study NCT05289999 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality headset for first injection
Description: Performing the first ultrasound-guided epidural injection through the sacrococcygeal hiatus using the virtual reality headset
Study NCT05289999 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality headset for second injection
Description: Performing the second ultrasound-guided epidural injection through the sacrococcygeal hiatus using the virtual reality headset
Study NCT05649046 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: thoracic scan Low dose
Description: within 3 months after the V0 visit
Study NCT06162533 — intervention group
Intervention type: BIOLOGICAL
Intervention: Vaccination against SARS-CoV-2
Description: Interventions are either a vaccination against SARS-CoV-2 or an infection with SARS-CoV-2
Study NCT05649046 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: BLOOD SAMPLE
Description: within 3 months after the V0 visit
Study NCT05649046 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: FECES SAMPLE
Description: within 3 months after the V0 visit
Study NCT05136612 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional physiothrapy
Description: Conventional physiotherapy program will be applied to the control group for 6 weeks, 3 days a week, 45 minutes a day. Strengthening, dynamic stretching, coordination and balance exercises and functional exercises for upper and lower extremities will be applied in this treatment program.
Study NCT05136612 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: robotic rehabilitation
Description: The study group will be included in the rehabilitation program with the Hocoma brand Armeo Spring pediatric upper extremity robot for 30 minutes a day, 3 days a week, for 6 weeks at hospital. Armeo spring robot enables the individual to perform active movement by carrying the weight of the upper extremity of children who have active movement in their upper extremities but do not have enough strength to overcome gravity with their upper extremities. The individual is actively involved in the study during the study. With the adjustments made, it becomes suitable for use for right and left extremities. In the process of working; The games named High Flyer, Frisbee, Balloons, Goalkepper, Save the Monster, Fishing, Helicopter Rescue, which are included in the Armeo Spring robot and created to increase shoulder, elbow and wrist movements, will be used.
Study NCT05024357 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasatinib
Description: Take Dasatinib orally for 1 year or 6 months post-HSCT.
Study NCT06160362 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CART-19 and 20 cells
Description: Double-target CART-19 and 20 cells will be administered on day0 after completion of the chemotherapy.
Study NCT06160362 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: patients will receive a standard pre-conditioning regime with cyclophosphamide 500mg/m2/day IV for 2 days(Day-3 to day-2).
Study NCT06160362 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine 25mg/m2/day IV for 3 days (Day-4 to day-2).
Study NCT04775485 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DAY101
Description: DAY101 is an oral pan-RAF inhibitor provided as an immediate-release tablet (100 mg) or powder for reconstitution (25 mg/mL).
Study NCT04721522 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood sampling & ultrasound
Description: Blood sampling:~Serum P4 \& estradiol will be performed on the day of triggering and on the day of embryo transfer. Progesterone/ Estradiol (P4/E2) ratio will be calculated Ultrasound: On triggering day, at time of ovum pick up and on ET day, we will measure~1. Endometrial thickness~2. Endometrial pattern~3. Endometrial compaction: the difference in measurement of endometrial thickness between the day of embryo transfer and the day of triggering.~4. Junctional zone thickness~5. Uterine contraction (peristalsis).~6. Blood flow of uterine vessels: PI of the uterine arteries will be calculated also Endometrial - sub endometrial blood flow
Study NCT05304429 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: nutrition education
Description: Educational sessions with topics that will address the management and prevention of frailty syndrome focusing on protein intake and physical activity
Study NCT05304429 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: nutritional counseling
Description: nutritional counseling system based on the com-b model through three strategies: goal setting, self-monitoring and social support
Study NCT04973462 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: standard treatment COVID-19 + Triazavirin
Description: to evaluate the efficacy and safety (side effects and / or adverse effects) of Triazavirin and Oseltamivir as treatment of Coronavirus Disease 2019
Study NCT06385535 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Habit Reversal Training (HRT)
Description: Habit Reversal Training (HRT) is a multicomponent treatment package developed to treat a repetitive behaviors. HRT includes (1) increasing awareness of discrete occurrences of tics and associated premonitory urges (PMUs; i.e., awareness training), (2) teaching the patient to suppress tics by engaging in behaviors that are physically incompatible with target tics (i.e., competing response \[CR\] training), and (3) prompting and reinforcing between-session patient engagement with therapeutic techniques and homework (i.e., providing social support).
Study NCT05069207 — intervention group
Intervention type: OTHER
Intervention: POWER breathe K5
Description: Maximum inspiratory pressure (MIP) and volume (Volume (V)) parameters will be evaluated with the POWER breathe K5 to evaluate
Study NCT05390944 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMP4297(20mg)
Description: Single oral dose of IMP4297 administered under fasting conditions 5\*20 mg capsules in first intervention period and 10\*10 mg capsules in second intervention period (after washout period: at least 7 days)
Study NCT05390944 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMP4297(10mg)
Description: Single oral dose of IMP4297 administered under fasting conditions 10\*10 mg capsules in first intervention period and 5\*20 mg capsules in second intervention period (after washout period: at least 7 days)
Study NCT04565431 — intervention group
Intervention type: DRUG
Intervention: Tysabri
Description: Participants with RRMS who are planning to begin treatment with Tysabri will be compared to a group of healthy individuals who are matched for age, gender, and education.
Study NCT04592926 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Accuro SpineNav3D
Description: The intervention will consist of a pre-procedural scan of the lumbar spine using the handheld image guidance device, Accuro, to determine spinal landmarks and anticipated depth of the intrathecal space.
Study NCT05178966 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bp OneDay psychoeducation program
Description: The BP One-Day Psychoeducation program is based on a single day of psychoeducation . This program was carried out by members of the bipolar expert center network in various hospitals of the network and included :~* Representation of BD~* Definition, diagnosis and awareness of the disorder~* Depressive, hypo / manic symptoms~* Vulnerability to BD causes of BD, risk factors for relapses~* Drug treatments, drug compliance and non-drug treatments~* Early detection of prodromal signs~* Communication techniques~Each BP One-Day psychoeducation session welcomes an average of ten participants (5 patients / 5 caregivers). At the end of the day, participants receive a booklet containing the main information of the day.~BP One-Day program is delivered by a nurse and a psychologist specialized in both BD and therapy group facilitation. A specialized psychiatrist intervenes in the section Medication treatments and medication adherence for a period of approximately one hour.
Study NCT06368960 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Radiation： Hypofractionated radiotherapy
Study NCT06368960 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BM201 injection
Description: BM201 injection：Dose escalation：24mg to 240mg
Study NCT06341972 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy based self-management for anxiety
Description: Evidenced based approach for educating patients about how to manage anxiety after respiratory failure.
Study NCT05315531 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Water Intake
Description: Participants will increase plain water consumption to at least 70% of the daily adequate intake for Americans depending on their sex.
Study NCT05515653 — intervention group
Intervention type: GENETIC
Intervention: Exposure to genetics (polygenic)
Description: The polygenic risk score (PRS) aggregates the effects of genetic variants into a single number that predicts the genetic predisposition to a phenotype. PRS are typically composed of hundreds to millions of genetic variants, usually Single Nucleotide Polymorphisms (SNPs). For each individual, the number of risk alleles computed in each variant is summed and weighted by the estimated value of the obtained effects (log odds ratio for traits with binary values or Beta coefficients for traits with continuous value) obtained from large-scale genomic studies ( GWAS)
Study NCT06000462 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg Tab
Description: Mentioned in detailed description.
Study NCT06000462 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin 10mg Tab
Description: Mentioned in detailed description.
Study NCT06000462 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dapagliflozin 10mg Tab
Description: Mentioned in detailed description.
Study NCT04592926 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: The sham group will receive a pre-procedure sham scan (the handheld image guidance Accuro device will be placed on the back, but it will be turned off) followed by sham marking on the subject's back.
Study NCT06459544 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Bobath Technique with core stability
Description: exercise to improve balance motor learning stretegy is basically used. Bobath in which we assess patient's posture, inhibit the abnormal muscle tone and facilitate normal patterns and posture through handling and posture. we also use sensory inputs like propioception to promote normal pattern. we take some exercise based on bobath technique with core stability like Bridging with core stability, quadroped with core stability, sitting and standing with core stablity, single leg standing , dynamic balance with core stability.treatment plan based on 45 minutes per day, 6 days a week for 4 week.
Study NCT06459544 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional treatment for balance
Description: like stretching, strenthening the Lower extremity muscles , PROMS, AAROMS,AROMS, RROMS,some balance exercise like sitting and standing
Study NCT04890457 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation via tragus
Description: The device will send stimulus intensity around 0.5mA via tragus in the left ear (based on participants' subjective report), delivered with a pulse width of 0.25 ms at 25 Hz. Stimulation will be active for 30 seconds, followed by a break of 30 seconds.
Study NCT04890457 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham stimulation via earlobe
Description: The device will send stimulus intensity around 0.5mA via earlobe in the left ear (based on participants' subjective report), delivered with a pulse width of 0.25 ms at 25 Hz. Stimulation will be active for 30 seconds, followed by a break of 30 seconds.
Study NCT05892445 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Graphic Warning Labels
Description: Based on a thorough review of the literature on e-cigarette risks and adverse effects, a graphic designer will be contracted to create ten experimental aversive health warnings related to e-cigarettes. These warnings will be exported as high-quality images and shown to participants in the intervention group prior to questions that obtain data on the primary endpoint.